Intelligent Bio Solutions publishes investor presentation on fingerprint sweat drug screening system

• Intelligent Bio Solutions outlined commercialization of its fingerprint sweat-based drug screening system targeting rapid, non-invasive workplace testing.
• System screens for recent drug use with a 16–24 hour detection window, positioning product around “fitness for duty” versus urine or saliva testing.
• Deck highlighted testing workflow delivering results in under 10 minutes, with validation work underway on a cartridge targeting 70% faster turnaround.
• Company also presented SmarTest wearable sweat patch for continuous monitoring over 7–10 days, aimed at broader substance detection.
• Presentation cited 480+ active customer accounts across 27 countries, with U.S. expansion tied to planned FDA clearance for codeine detection.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.